The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Top Value Effervescent Pain Relief
Aspirin, Citric Acid, Sodium Bicarobonate · SODIUM BICARBONATE 1916 mg/1; ASPIRIN 325 mg/1; ANHYDROUS CITRIC ACID 1000 mg/1 · Tablet, Effervescent · Oral · Tower Laboratories Ltd
NDC 50201-4213-06 · 18 POUCH in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 POUCH · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Opioid Analgesic REMS Shared System REMS
Regulatory
- Application
- M013
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Aspirin, Citric Acid, Sodium Bicarobonate (Tablet, Effervescent)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Tower Laboratories Ltd | SODIUM BICARBONATE 1916 mg/1; ASPIRIN 325 mg/1; ANHYDROUS CITRIC ACID 1000 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Tower Laboratories Ltd | SODIUM BICARBONATE 1000 mg/1; ASPIRIN 325 mg/1; ANHYDROUS CITRIC ACID 1916 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Tower Laboratories Ltd | ANHYDROUS CITRIC ACID 1000 mg/1; ASPIRIN 325 mg/1; SODIUM BICARBONATE 1916 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Top Value Effervescent Pain Relief — NDC 50201-4213-06," retrieved September 3, 2026, https://drugdashboards.com/drug/50201421306.
Free to cite with attribution — see how the data is put together.